The Patent Finder

Terms ending in 2036

Araxes Pharma LLC

Every in-force patent on Araxes Pharma LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,246,424Substituted Quinazoline Compounds and Methods of Use Thereof
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
US RE50,490Substituted Quinazoline Compounds and Methods of Use Thereof
In force
 · Low confidence
Araxes Pharma LLCIn forceLow confidence
US 10,428,064Fused-Tricyclic Inhibitors of Kras and Methods of Use Thereof
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
US 10,858,343Inhibitors of Kras G12C Mutant Proteins
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
US 10,647,703Inhibitors of Kras G12C Mutant Proteins
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
US 10,730,867Inhibitors of Kras G12C Mutant Proteins
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
US 10,875,842Inhibitors of Kras G12C Mutant Proteins
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
US 10,689,356Inhibitors of Kras G12C Mutant Proteins
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
US 10,975,071Inhibitors of Kras G12C Mutant Proteins
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
US 10,414,7572-Substituted Quinazoline Compounds Comprising a Substituted Heterocyclic Group and Methods of Use Thereof
In force
 · High confidence
Araxes Pharma LLCIn forceHigh confidence
2 more term ends in 2036 · Pro
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Upgrade to Pro
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited